Sign in
LSB Stock Price, Chart, Stats & News
LakeShore Biopharma Co., Ltd
Save
25.84M
Market cap
–
Current P/E
–
Forward P/E
LSB chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 82.47% |
Operating margin | -14.03% |
Pretax margin | -16.41% |
Net margin | -16.26% |
Effective tax rate | 0.94% |
ROA | -7.31% |
ROE | -18.43% |
D/E | 0.83x |
Interest coverage ratio | -5.48x |
LSB valuation
P/E | – |
P/S | 0.29x |
P/B | 0.93x |
P/CF | -3.83x |
P/FCF | -1.29x |
P/OCF | -3.83x |
PEG | -0.01x |
EV multiple | 4.28x |
About
LakeShore Biopharma Co., Ltd is a biopharmaceutical firm focused on the discovery, advancement, manufacturing, and marketing of vaccines and therapeutic biologics. Its primary targets are infectious diseases and various forms of cancer. At the core of its innovation is a proprietary PIKA immunomodulating technology platform, which underpins its product pipeline, featuring a PIKA rabies vaccine, a PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.
Similar securities
Based on sector and market capitalization
Report issue